| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0885328211429495 |
| P698 | PubMed publication ID | 22207601 |
| P2093 | author name string | Wen-Yuan Hsieh | |
| Wen-Fu Lee | |||
| Yung-Chu Chen | |||
| Ding-Tai Zeng | |||
| P2860 | cites work | The expression of native and oxidized LDL receptors in brain microvessels is specifically enhanced by astrocytes-derived soluble factor(s) | Q28577554 |
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats | Q32044245 | ||
| Nanoparticulate systems for brain delivery of drugs | Q33938252 | ||
| Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. | Q33982544 | ||
| Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain | Q33982602 | ||
| Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes | Q34060092 | ||
| Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease | Q35067452 | ||
| Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions | Q36166105 | ||
| Active targeting of brain tumors using nanocarriers | Q36918333 | ||
| A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment | Q39765883 | ||
| Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters | Q39799499 | ||
| Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles | Q40002076 | ||
| Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier | Q40928488 | ||
| The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. | Q42011060 | ||
| Transferrin-conjugated nanoparticles of Poly(lactide)-d-α-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier | Q42951099 | ||
| The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats | Q43674677 | ||
| PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases | Q43762536 | ||
| Biodegradable block copolymers for delivery of proteins and water-insoluble drugs | Q44748796 | ||
| Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. | Q45105261 | ||
| Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables | Q46722147 | ||
| Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir | Q46757054 | ||
| Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier | Q47988449 | ||
| Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers | Q48106511 | ||
| Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants | Q48346110 | ||
| Nanoparticle technology for delivery of drugs across the blood-brain barrier | Q48352217 | ||
| Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. | Q48520343 | ||
| Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. | Q48536446 | ||
| Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. | Q48608387 | ||
| Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. | Q48614110 | ||
| Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. | Q48784173 | ||
| Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. | Q49030961 | ||
| Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. | Q49111527 | ||
| Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. | Q55473881 | ||
| P433 | issue | 7 | |
| P921 | main subject | nanoparticle | Q61231 |
| blood–brain barrier | Q221694 | ||
| loperamide | Q423751 | ||
| P304 | page(s) | 909-922 | |
| P577 | publication date | 2011-12-29 | |
| P1433 | published in | Journal of Biomaterials Applications | Q6294848 |
| P1476 | title | Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier | |
| P478 | volume | 27 |
| Q58611877 | A Tailored Thermosensitive PLGA-PEG-PLGA/Emulsomes Composite for Enhanced Oxcarbazepine Brain Delivery via the Nasal Route |
| Q61796364 | A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine |
| Q33845298 | Advanced Analgesic Drug Delivery and Nanobiotechnology. |
| Q39013235 | Biological and environmental surface interactions of nanomaterials: characterization, modeling, and prediction |
| Q28067855 | Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking |
| Q30354932 | Brain delivery of proteins via their fatty acid and block copolymer modifications |
| Q92534458 | Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson's |
| Q46847846 | Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide. |
| Q34637830 | Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration |
| Q40789506 | Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases |
| Q90644055 | Inverse-micelle synthesis of doxorubicin-loaded alginate/chitosan nanoparticles and in vitro assessment of breast cancer cytotoxicity |
| Q92663266 | Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics |
| Q48968218 | Nanoparticle accumulation and transcytosis in brain endothelial cell layers. |
| Q38275050 | Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance |
| Q39112084 | Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process |
| Q28390779 | Nanotechnology in drug delivery: the need for more cell culture based studies in screening |
| Q38321195 | Novel drug-delivery approaches to the blood-brain barrier |
| Q42111511 | Nucleic acids in human glioma treatment: innovative approaches and recent results |
| Q44334825 | Opioid-based micro and nanoparticulate formulations: alternative approach on pain management |
| Q59113665 | Recent Trends in Preparation of Poly(lactide-co-glycolide) Nanoparticles by Mixing Polymeric Organic Solution with Antisolvent |
| Q38827159 | Salinomycin encapsulated nanoparticles as a targeting vehicle for glioblastoma cells |
| Q38791884 | Targeted brain delivery nanoparticles for malignant gliomas. |
| Q38169707 | The use of lipid-based nanocarriers for targeted pain therapies |
| Q37338427 | Therapeutic nanomedicine for brain cancer |
| Q39177093 | Towards understanding the distribution and tumor targeting of sericin regulated spherical calcium phosphate nanoparticles |
Search more.